Initiating Medication-Assisted Treatment Induction in Emergency Departments
Initiating Medication-Assisted Treatment Induction in Emergency Departments Kate Slomkowski
Emergency Departments (EDs) are in a unique position of being able to initiate treatment of Opioid Use Disorder (OUD) through the induction of buprenorphine with follow-up referral to a recovery program, after critical health events and on a near 24/7 basis. Hospital administrators, clinicians, and community partners require additional training and assistance, on developing protocols which provide opportunities for the ED to offer buprenorphine induction services and successful connection to community services allowing individuals with OUD successful entry into ongoing treatment. The goal of this project is to increase the number of EDs that have policies and procedures in place to initiate buprenorphine treatment and refer to MAT resources in the community.
Quality Counts (QC), in collaboration with BlueWater Emergency Partners and several other partners (MMA and ACEP) is working under a contract with the state of Maine to host an education program for interested hospital Emergency Departments (EDs) focusing on how to initiate buprenorphine in the ED. During the Rapid Induction Starting in the ED (RISE) project, QC plans to offer a range of learning methods, including both in-person and virtual events, to provide education and assistance on best practices for initiating buprenorphine in hospital EDs for individuals with Substance Use Disorder (SUD) who are willing to engage in treatment during an ED visit.
This is an ongoing project, please check back for results at the conclusion of the contract.